Coordination and optimization of FDG PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
McIntosh, Lacey J.Rosen, Max P
Mittal, Kriti
Whalen, Giles F.
Bathini, Venu G.
Ali, Tasneem
Edmiston, Kathryn L.
Walsh, William V.
Gerber, Jonathan M.
UMass Chan Affiliations
Department of Surgery, Division of Surgical OncologyDepartment of Medicine, Division of Hematology Oncology
Department of Radiology
Document Type
Journal ArticlePublication Date
2021-05-11Keywords
Oncologic imagingCOVID-19 vaccine
vaccination
cancer
FDG PET/CT
Diagnosis
Hemic and Lymphatic Diseases
Infectious Disease
Neoplasms
Oncology
Public Health
Radiology
Virus Diseases
Metadata
Show full item recordAbstract
As the world embarks on mass vaccination for COVID-19, we are beginning to encounter unintended dilemmas in imaging oncology patients; particularly with regards to FDG PET/CT. In some cases, vaccine-related lymphadenopathy and FDG uptake on PET/CT can mimic cancer and lead to confounding imaging results. These cases with findings overlapping with cancer pose a significant dilemma for diagnostic purposes, follow-up, and management leading to possible treatment delays, unnecessary repeat imaging and sampling, and patient anxiety. These cases can largely be avoided by optimal coordination between vaccination and planned imaging as well as preemptive selection of vaccine administration site. This coordination hinges on patient, oncologist, and radiologists’ awareness of this issue and collaboration. Through close communication and patient education, we believe this will eliminate significant challenges for our oncology patients as we strive to end this pandemic.Source
McIntosh LJ, Rosen MP, Mittal K, Whalen GF, Bathini VG, Ali T, Edmiston KL, Walsh WV, Gerber JM. Coordination and optimization of PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination. Cancer Treatment Reviews. 2021 May 11.
DOI
10.1016/j.ctrv.2021.102220Permanent Link to this Item
http://hdl.handle.net/20.500.14038/27428PubMed ID
34029956ae974a485f413a2113503eed53cd6c53
10.1016/j.ctrv.2021.102220